Comerica Bank
AVXL icon

Comerica Bank’s Anavex Life Sciences AVXL Stock Holding History

Comerica Bank’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$12.9K Buy
+3,610
New +$22.1K ﹤0.01% 3191
2024
Q3 		– Sell
-112
Closed -$473 – 3678
2024
Q2 		$473 Hold
112
– – ﹤0.01% 3625
2024
Q1 		$570 Buy
+112
New +$630 ﹤0.01% 3671

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Comerica Bank's AVXL Position: Q4 2025 in Review

Comerica Bank opened a new position in Anavex Life Sciences (AVXL) in Q4 2025: 3,610 shares worth $12.9K. The stake represents ﹤0.01% of the portfolio and ranks #3191 among its holdings. This is a return to the name: Comerica Bank previously reported a position in AVXL as recently as Q2 2024.

Comerica Bank first reported a position in AVXL in Q1 2024 and has held it in 3 quarters since. 184 funds tracked by Wall St. Rank hold AVXL as of Q4 2025.

  • Comerica Bank held 3,610 shares of Anavex Life Sciences worth $12.9K as of Q4 2025.
  • Anavex Life Sciences was a new Comerica Bank position in Q4 2025.
  • Anavex Life Sciences made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3191 holding.
  • Comerica Bank first reported a position in Anavex Life Sciences in Q1 2024 and has held it in 3 quarters since.
  • 184 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.